University of Alabama at Birmingham
Maria Danila, MD, MSc, MSPH
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Rheumatologic Disease
Autoimmune Diseases
Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
Video on the importance of good oral health for patients with AIRD
Brochure on COVID-19 vaccination in AIRD patients
Patient Navigation
Brochure on the importance of good oral health in AIRD patients
NA
Black and Latinx persons are at higher risk for certain autoimmune and inflammatory rheumatic diseases (AIRD) and have experienced worse COVID-19 outcomes compared to their white counterparts. Given the risks of severe COVID-19 outcomes such as hospitalization and death in people with AIRD, COVID-19 vaccine is recommended in this population. Historically, overall vaccine uptake among people with AIRDs has been low, and this vaccine reluctance has extended to COVID-19 vaccination. While additional COVID-19 vaccine doses have offered considerable added protection against severe outcomes, only 20% of all vaccinated persons in Alabama (AL) and 45% in Massachusetts have obtained an additional dose of COVID-19 vaccine as of October 2022. Racial and ethnic minority groups have faced disparities in obtaining subsequent COVID-19 vaccines, particularly in under-resourced communities, including those in Alabama and Massachusetts. Together, these obstacles exacerbate existing health inequities among people of color and perpetuate worse COVID-19 outcomes. We will conduct a randomized controlled study to test an intervention that seeks to address gaps in COVID-19 vaccine information and access inequities common in Black and Latinx populations.
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 1170 participants |
| Masking : | DOUBLE |
| Primary Purpose : | HEALTH_SERVICES_RESEARCH |
| Official Title : | Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases |
| Actual Study Start Date : | 2024-12-18 |
| Estimated Primary Completion Date : | 2027-04-30 |
| Estimated Study Completion Date : | 2027-08-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Alabama at Birmingham
Birmingham, alabama, United States, 35294
NOT YET RECRUITING
Brigham Women's Hospital
Boston, Massachusetts, United States, 02115
NOT YET RECRUITING
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States, 01655